- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Profitable Climbers
Norwegian Pharmaceuticals & Biotech Profitable Climbers
Results
2
0 new
2 companies
Photocure
Market Cap: NOK 1.9b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 70.60
7D
-0.1%
1Y
20.5%
ArcticZymes Technologies
Market Cap: NOK 1.1b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 21.40
7D
1.9%
1Y
50.7%